Pannex Therapeutics
PrivateLast Round
Follow-on Offering
Jan 1, 2022
Total Funding Raised
$2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Pannex Therapeutics operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Follow-on Offering round in January 2022.
Pannex Therapeutics is a biotechnology company developing first-in-class Panx1 channel blockers to treat chronic neuropathic pain and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pannex Therapeutics Comparables
Compare Pannex Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Akelos Inc. | 88% | |
| Bahto Biosciences | 83% | |
| Algiax Pharmaceuticals | 80% |
For institutional investors. Book with your work email.
Pannex Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Jan 1, 2022 |
For institutional investors. Book with your work email.
Pannex Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SOSV | Follow-on Offering |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 32% MoM.
- Jul 25, 2026
Monthly visitors increased 797% MoM.
For institutional investors. Book with your work email.
Pannex Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pannex Therapeutics's valuation, stock price, and market status.
Is Pannex Therapeutics a public or private company?
Pannex Therapeutics is a private company.
What is the current stock price of Pannex Therapeutics?
Pannex Therapeutics is a private company, so its shares have no public market price. Caplight tracks Pannex Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pannex Therapeutics worth (valuation)?
Valuation information for Pannex Therapeutics is not publicly available.
Can I buy Pannex Therapeutics stock?
Pannex Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pannex Therapeutics's last funding round?
Pannex Therapeutics's most recent funding round was Follow-on Offering on January 1, 2022.
Who are the main investors in Pannex Therapeutics?
Key investors in Pannex Therapeutics include SOSV.
Will Pannex Therapeutics IPO soon?
No public IPO plans have been announced for Pannex Therapeutics.
How can I track Pannex Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Pannex Therapeutics's shares on secondary markets.